GBA1 and Parkinson disease: Aharon-Peretz and her colleagues [2] reported that the overall clinical manifestations and age at disease onset have no differences in PD patients with GBA mutations (GBA + PD) compared with those without mutations (GBA − PD) in 148 Ashkenazi PD patients.